Announcements Trials
Browse Landscape

Phase

Phase 1 240Phase 1/2 94Phase 2 13Phase EARLY_PHASE1 4

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Multiple Myeloma 19Solid Tumor 18Breast Neoplasms 14Sarcoma 13Head and Neck Neoplasms 13Colorectal Neoplasms 13Neoplasms 12Lymphoma, B-Cell 12Squamous Cell Carcinoma of Head and Neck 11Pancreatic Neoplasms 11Leukemia, Myeloid, Acute 11Stomach Neoplasms 10Melanoma 10Lymphoma 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Prostatic Neoplasms 7Leukemia 7Burkitt Lymphoma 7Advanced Solid Tumors 7Ovarian Neoplasms 6Hematologic Neoplasms 6Glioblastoma 6Recurrence 5Osteosarcoma 5Lymphoma, Non-Hodgkin 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Neoplasm Metastasis 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × INDUSTRY × Advanced Solid Tumor × Clear all
NCT06488950 2025-12-16

A Study of TIL in Advanced Solid Tumors (DFGD)

Shanghai Juncell Therapeutics

Phase EARLY_PHASE1 Recruiting
30 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT05908773 2025-01-28

A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors

TransCode Therapeutics

Phase EARLY_PHASE1 Completed
1 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT05087745 2024-04-17

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Shanghai Juncell Therapeutics

Phase EARLY_PHASE1 Unknown
50 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06266923 2024-02-20

A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.

Shanghai Pharmaceuticals Holding Co., Ltd

Phase EARLY_PHASE1 Completed
16 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡